Rita Silvério

PhD Student (External)


  • 2014 - 2016: Prediction of Drug Targets in Human Pathogens

Recent Publications

1
Retrieval of Enterobacteriaceae drug targets using singular value decomposition
  • Bioinformatics, 31(8), 1267-1273, 2015
2
Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel comt inhibitor, during first administration to healthy male subjects
  • Parkinsonism & Related Disorders, S126, 2012
3
Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel comt inhibitor, during multiple rising dose regimens in healthy male subjects
  • Parkinsonism & Related Disorders, S126, 2012
4
In-vivo evaluation of prolonged release bilayer tablets of anti-Parkinson drugs in Göttingen minipigs
  • Journal of Pharmacy and Pharmacology, 63(6), 780-785, 2011
5
Pharmacokinetic pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: A single-center, phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects
  • Clinical Therapeutics, 31(10), 2258-2271, 2009
6
Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg
  • Drugs in R & D, 9(6), 435-446, 2008
7
Pharmacokinetic-Pharmacodynamic Interaction Between Nebicapone (BIA 3-202) and Controlled-release Levodopa/Benserazide (Madopar HBS 125)
  • Neurotherapeutics, 5(3), 492, 2008
8
Pharmacokinetic–Pharmacodynamic Interaction Between BIA 3-202, a Novel COMT Inhibitor, and Levodopa/Carbidopa
  • Clinical Neuropharmacology, 27(1), 17-24, 2004
9
Pharmacokinetic–pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide
  • European Journal of Clinical Pharmacology, 59(8), 603-609, 2003
Full List